100 related articles for article (PubMed ID: 27132089)
1. Factors influencing primary treatment of midline vulvar cancers.
Conrad LB; Conrad SA; Miller DS; Richardson DL; Kehoe S; Lea JS
Gynecol Oncol; 2016 Jul; 142(1):133-138. PubMed ID: 27132089
[TBL] [Abstract][Full Text] [Related]
2. Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation.
Landrum LM; Skaggs V; Gould N; Walker JL; McMeekin DS
Gynecol Oncol; 2008 Mar; 108(3):584-90. PubMed ID: 18155755
[TBL] [Abstract][Full Text] [Related]
3. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection.
Fonseca-Moutinho JA; Coelho MC; Silva DP
J Reprod Med; 2000 Aug; 45(8):672-8. PubMed ID: 10986688
[TBL] [Abstract][Full Text] [Related]
4. Vulvar carcinoma.
Anderson JM; Cassady JR; Shimm DS; Stea B
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1351-7. PubMed ID: 7635775
[TBL] [Abstract][Full Text] [Related]
5. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis.
Chan JK; Sugiyama V; Pham H; Gu M; Rutgers J; Osann K; Cheung MK; Berman ML; Disaia PJ
Gynecol Oncol; 2007 Mar; 104(3):636-41. PubMed ID: 17095080
[TBL] [Abstract][Full Text] [Related]
6. Should Groin Recurrence Still Be Considered as a Palliative Situation in Vulvar Cancer Patients?: A Brief Report.
Frey JN; Hampl M; Mueller MD; Günthert AR
Int J Gynecol Cancer; 2016 Mar; 26(3):575-9. PubMed ID: 26894938
[TBL] [Abstract][Full Text] [Related]
7. Primary Versus Preoperative Radiation for Locally Advanced Vulvar Cancer.
Natesan D; Hong JC; Foote J; Sosa JA; Havrilesky L; Chino J
Int J Gynecol Cancer; 2017 May; 27(4):794-804. PubMed ID: 28333840
[TBL] [Abstract][Full Text] [Related]
8. Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma.
Nooij LS; Ongkiehong PJ; van Zwet EW; Bosse T; Creutzberg CL; Gaarenstroom KN; van Poelgeest MI
Gynecol Oncol; 2015 Dec; 139(3):458-64. PubMed ID: 26432039
[TBL] [Abstract][Full Text] [Related]
9. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients.
Burger MP; Hollema H; Emanuels AG; Krans M; Pras E; Bouma J
Gynecol Oncol; 1995 Jun; 57(3):327-34. PubMed ID: 7774836
[TBL] [Abstract][Full Text] [Related]
10. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma.
Parthasarathy A; Cheung MK; Osann K; Husain A; Teng NN; Berek JS; Kapp DS; Chan JK
Gynecol Oncol; 2006 Dec; 103(3):1095-9. PubMed ID: 16889821
[TBL] [Abstract][Full Text] [Related]
11. [PROGNOSTIC MODELS IN MODERN MANAGEMENT OF VULVAR CANCER].
Tsvetkov Ch; Gorchev G; Tomov S; Nikolova M; Genchev G
Akush Ginekol (Sofiia); 2016; 55(1):17-26. PubMed ID: 27514127
[TBL] [Abstract][Full Text] [Related]
12. Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: time to reconsider the FIGO staging system?
Thaker NG; Klopp AH; Jhingran A; Frumovitz M; Iyer RB; Eifel PJ
Gynecol Oncol; 2015 Feb; 136(2):269-73. PubMed ID: 25524458
[TBL] [Abstract][Full Text] [Related]
13. T2/3 vulva cancer: a case-control study of triple incision versus en bloc radical vulvectomy and inguinal lymphadenectomy.
Siller BS; Alvarez RD; Conner WD; McCullough CH; Kilgore LC; Partridge EE; Austin JM
Gynecol Oncol; 1995 Jun; 57(3):335-9. PubMed ID: 7774837
[TBL] [Abstract][Full Text] [Related]
14. [Results of an individualized surgical therapy of vulvar carcinoma from 1973-1993].
Köhler U; Schöne M; Pawlowitsch T
Zentralbl Gynakol; 1997; 119 Suppl 1():8-16. PubMed ID: 9245126
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy.
Kirby TO; Rocconi RP; Numnum TM; Kendrick JE; Wright J; Fowler W; Mutch DG; Bhoola SM; Huh WK; Straughn JM
Gynecol Oncol; 2005 Aug; 98(2):309-12. PubMed ID: 15975642
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study.
Mahner S; Jueckstock J; Hilpert F; Neuser P; Harter P; de Gregorio N; Hasenburg A; Sehouli J; Habermann A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Thiel F; Mustea A; Meier W; du Bois A; Griebel LF; Woelber L;
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25618900
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer.
Zapardiel I; Gracia M; Díez J; Buda A; Noya MC; Iaco P; Vieira-Baptista P; Iacoponi S;
Arch Gynecol Obstet; 2021 Mar; 303(3):759-766. PubMed ID: 33067709
[TBL] [Abstract][Full Text] [Related]
18. Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma.
Viswanathan AN; Pinto AP; Schultz D; Berkowitz R; Crum CP
Gynecol Oncol; 2013 Sep; 130(3):545-9. PubMed ID: 23747330
[TBL] [Abstract][Full Text] [Related]
19. Two-team simultaneous total radical vulvectomy and inguino-femoral lymphadenectomy via separate incisions for locally advanced (FIGO stages IB ≥ 4 cm-III) squamous vulvar cancer.
Fambrini M; Sorbi F; Sisti G; Checcucci V; Cariti G; Scotti V; Tinacci E; Turrini I; Micaglio M; De Magnis A
Anticancer Res; 2014 Dec; 34(12):7345-50. PubMed ID: 25503170
[TBL] [Abstract][Full Text] [Related]
20. Exenteration in the treatment of Stage III/IV vulvar cancer.
Forner DM; Lampe B
Gynecol Oncol; 2012 Jan; 124(1):87-91. PubMed ID: 21992967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
